The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
Cell & Gene: The Podcast
00:00
Breakthrough in RRP Treatment: A Landmark Achievement
This chapter highlights a significant advancement in the treatment of recurrent respiratory papillomatosis, including the recent breakthrough designation and the upcoming submission of a rolling Biologics License Application. The discussion emphasizes the excitement around trial results and sets the stage for future commercialization plans in 2025.
Transcript
Play full episode
